Referências

1. Bertram MY, 2016, B WORLD HEALTH ORGAN, V94, P925, DOI 10.2471/BLT.15.164418
2. Campolina AG, 2017, APPL HEALTH ECON HEA, V15, P163, DOI 10.1007/s40258-016-0290-x
3. Claxton K, 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19140
4. Departamento de Ciencia e Tecnologia Secretaria de Ciencia Tecnologia e Insumos Estrategicos Ministerio da Saude, 2014, DIR MET DIR AV EC
5. Eichler HG, 2004, VALUE HEALTH, V7, P518, DOI 10.1111/j.1524-4733.2004.75003.x
6. Griffiths UK, 2016, HEALTH ECON, V25, P29, DOI 10.1002/hec.3312
7. Irish Pharmaceutical Healthcare Association, Health Service Executive, 2012, FRAM AGR IR PHARM HE
8. Kaplan RM, 1982, HEALTH PSYCHOL, V1, P61, DOI 10.1037/0278-6133.1.1.61
9. LAUPACIS A, 1992, CAN MED ASSOC J, V146, P473
10. Pinto M, 2016, J BRAS EC SAUDE, V8, P58
11. Pitt C, 2016, HEALTH ECON, V25, P1, DOI 10.1002/hec.3319
12. Prado CCL, 2015, REV ELETRONICA GESTA, V6, P3127
13. Robinson LA, 2017, HEALTH POLICY PLANN, V32, P141, DOI 10.1093/heapol/czw096
14. Schwarzer R, 2015, J COMP EFFECT RES, V4, P485, DOI 10.2217/cer.15.38
15. Thavorncharoensap Montarat, 2013, Clinicoecon Outcomes Res, V5, P29, DOI 10.2147/CEOR.S38062
16. Weinstein M, 1973, J PUBLIC ECON, V2, P147, DOI 10.1016/0047-2727(73)90002-9
17. World Health Organization, 2001, MACR HLTH INV HLTH E
18. Woods B, 2015, 109 CHE U YORK CTR H
19. Woods B, 2016, VALUE HEALTH, V19, P929, DOI 10.1016/j.jval.2016.02.017
20. Yuba TY, 2015, VALUE HEALTH, V18, pA523, DOI 10.1016/j.jval.2015.09.1604
21. Zimmermann IR, 2015, REV ELETRONICA GESTA, V6, P3043